Patent · US Active

Estrogen receptor modulators and uses thereof

US8299112B2 · kind B2 · utility

31Cited by

6References

12Claims

0Family size

Assignee

Aragon Pharmaceuticals, Inc. · US

Inventors

Nicholas D. Smith · San Diego, US
Mehmet Kahraman · Village of La Jolla, US
Steven P. Govek · San Diego, US
Johnny Y. Nagasawa · San Diego, US
Andiliy G. Lai · San Diego, US
Jackaline D. Julien · Del Mar, US
Celine Bonnefous · San Diego, US

Key dates

Filing date	Sep 15, 2011
Grant date	Oct 30, 2012
Priority date	—
Expiry date	Sep 15, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.